Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:983942.
doi: 10.4061/2011/983942. Epub 2011 Dec 14.

Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations

Affiliations

Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations

Joseph P Pillion et al. Genet Res Int. 2011.

Abstract

Osteogenesis imperfecta (OI) is the most common heritable disorder of connective tissue. It is associated with fractures following relatively minor injury, blue sclerae, dentinogenesis imperfecta, increased joint mobility, short stature, and hearing loss. Structures in the otic capsule and inner ear share in the histologic features common to other skeletal tissues. OI is due to mutations involving several genes, the most commonly involved are the COL1A1 or COL1A2 genes which are responsible for the synthesis of the proalpha-1 and proalpha-2 polypeptide chains that form the type I collagen triple helix. A genotype/phenotype relationship to hearing loss has not been established in OI. Hearing loss is commonly found in OI with prevalence rates ranging from 50 to 92% in some studies. Hearing loss in OI may be conductive, mixed, or sensorineural and is more common by the second or third decade. Treatment options such as hearing aids, stapes surgery, and cochlear implants are discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. McKusick VA. Heritable disorders of connective tissue. V. Osteogenesis imperfecta. Journal of Chronic Diseases. 1956;3(2):180–202. - PubMed
    1. Marini JC, Cabral WA, Barnes AM. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell and Tissue Research. 2010;339(1):59–70. - PMC - PubMed
    1. Becker J, Semler O, Gilissen C, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. American Journal of Human Genetics. 2011;88(3):362–371. - PMC - PubMed
    1. Baldridge D, Schwarze U, Morello R, et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Human Mutation. 2008;29(12):1435–1442. - PMC - PubMed
    1. Homan EP, Rauch F, Grafe I, et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. Journal of Bone and Mineral Research. 2011;26(12):2798–2803. - PMC - PubMed

LinkOut - more resources